Oryzon Genomics Expands Capital with €30 Million Share Issuance
Deal News | Apr 30, 2025 | Iberian Lawyer
Gómez-Acebo & Pombo (GA_P) has successfully advised Oryzon Genomics, a publicly listed biotechnology company, on its recent capital increase. The firm facilitated the issuance of over 12.7 million new ordinary shares priced at €2.35 each, culminating in a capital injection of €30 million. The transaction was executed via an accelerated bookbuild offering. The newly raised capital aims to fortify Oryzon's financial structure, support its planned IPO on Nasdaq, and fund the expansion of its clinical programs in neuroscience and oncology. GA_P's Corporate and Capital Markets team, including partner Augusto Piel and associates Jacobo Palanca and Irene Carreo Ura, led the advisory effort.
Sectors
- Biotechnology
- Finance & Investments
Geography
- Spain – Oryzon Genomics and Gómez-Acebo & Pombo are based in Spain.
- United States – The article mentions Oryzon's plans to prepare for an IPO on Nasdaq, based in the USA.
Industry
- Biotechnology – The article revolves around Oryzon Genomics, a company within the biotechnology sector.
- Finance & Investments – The capital increase and planned Nasdaq IPO relate to financial and investment activities.
Financials
- €30 million – The total amount raised by Oryzon Genomics through the issuance of new shares.
- €2.35 per share – The price per share for the new ordinary shares issued by Oryzon Genomics.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Oryzon Genomics | Target | Company | A biotechnology company planning a capital increase and Nasdaq IPO. |
| Gómez-Acebo & Pombo (GA_P) | Legal Advisor | Company | A law firm advising Oryzon Genomics on the capital increase. |
| Augusto Piel | Partner | Person | A partner at Gómez-Acebo & Pombo involved in the advisory team for the transaction. |
| Jacobo Palanca | Associate | Person | An associate at Gómez-Acebo & Pombo involved in the advisory team for the transaction. |
| Irene Carreo Ura | Associate | Person | An associate at Gómez-Acebo & Pombo involved in the advisory team for the transaction. |